Brooklyn Investment Group’s Ascendis Pharma A/S ASND Stock Holding History

Brooklyn Investment Group’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$931K	Buy	4,072 +1,855	+84%	+$416K	0.03%	607
2025 Q4	$468K	Buy	+2,217	New	+$458K	0.02%	717
2025 Q3	–	Sell	-781	Closed	-$135K	–	811
2025 Q2	$135K	Buy	781 +426	+120%	+$69.4K	0.02%	784
2025 Q1	$55.3K	Buy	355 +273	+333%	+$39K	0.01%	735
2024 Q4	$11.3K	Buy	+82	New	+$10.8K	﹤0.01%	938

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Brooklyn Investment Group's ASND Position: Q1 2026 in Review

Brooklyn Investment Group increased its Ascendis Pharma A/S (ASND) stake by 84% in Q1 2026, buying an estimated $416K and bringing the position to 4,072 shares worth $931K. The position accounts for 0.03% of the portfolio, ranked #607.

Brooklyn Investment Group first reported a position in ASND in Q4 2024 and has held it in 5 quarters since. 274 funds tracked by Wall St. Rank hold ASND as of Q1 2026.

Brooklyn Investment Group held 4,072 shares of Ascendis Pharma A/S worth $931K as of Q1 2026.
Brooklyn Investment Group bought 1,855 Ascendis Pharma A/S shares in Q1 2026, an estimated $416K.
Ascendis Pharma A/S made up 0.03% of Brooklyn Investment Group's portfolio in Q1 2026, its #607 holding.
Brooklyn Investment Group first reported a position in Ascendis Pharma A/S in Q4 2024 and has held it in 5 quarters since.
274 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.